Developer docs
API playgroundTry for free, no card

Search company profiles

Innolitics

Full company profile

uuid000b2q7

Namestring
Innolitics
Legal namestring
Innolitics LLC
Websiteurl
innolitics.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Innolitics is an Austin, Texas-based engineering, regulatory, and management consulting firm founded in 2012 that focuses exclusively on AI-enabled medical device software (Software as a Medical Device). The firm helps medical device CEOs and founders convert clinical AI concepts into FDA-cleared, market-ready products by offering a vertically integrated delivery model that combines software engineering, FDA regulatory strategy, and cybersecurity compliance under a single engagement. Headquartered at 1101 West 34th St. #550, Innolitics operates as Innolitics LLC with no disclosed external institutional or venture funding and a headcount of 11–50 employees.

The service portfolio is organized around four core capabilities: end-to-end SaMD software development, FDA regulatory consulting (including 510(k), De Novo, Q-Sub, and Breakthrough Device Designation pathways), FDA cybersecurity documentation and hold-letter response, and Quality Management System implementation. Building on these services, Innolitics has productized a 'solutions' tier with fixed-scope, guaranteed-outcome offerings — 9-month AI/ML FDA clearance, 2-week BDD application, 4-week presub plus BDD, 2-month QMS delivery, and 3-month FDA hold-letter resolution. The firm also operates free public tools (an FDA Devices Database at fda.innolitics.com and a web-based DICOM Browser) and maintains an open-source Regulatory Documentation Manager (RDM) on GitHub, all of which function as lead-generation channels into the core services business.

Innolitics generates revenue through fixed-price or milestone-based professional services engagements; no public pricing is disclosed. Its customer base spans AI/ML medical imaging startups (Rology, Envisionit Deep AI, SimBioSys, Body Check, RadUnity, SmileDx/Cube Click, Neosoma, Prognosia Breast), enterprises (Varian Medical Systems, NVIDIA, Butterfly Network, Prenuvo, Indica Labs, Magnetic Insight, Transonic, AI Metrics, OXOS, Echo IQ, Enlitic, PhotoniCare), and academic institutions (Washington University School of Medicine, University of Alabama, Mary Bird Perkins Cancer Center), with reported cumulative outcomes of 60+ FDA-cleared products and 80+ devices shipped. The go-to-market motion is sales-led and relationship-based, targeting founders and regulatory teams at medical device companies through content marketing, a newsletter, and direct outreach.

Short descriptiontext

Innolitics is an Austin-based engineering and regulatory consulting firm that helps AI/ML medical device startups and enterprises achieve FDA clearance for SaMD products. Founded in 2012, the firm offers guaranteed-outcome services spanning software development, regulatory strategy, and cybersecurity compliance.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAustin, United States
HQ citystring
Austin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
FDA regulatory consulting, medical device software, AI/ML SaMD development, FDA 510(k) clearance, medical device cybersecurity
Industry3 codes
PRIMARYHLACANAN
DTx/SaMD Regulatory, Quality & Compliance Software (QMS/ISO/FDA)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAD
Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code2 codes
  • Computer Systems Design and Related Services54151
  • Other Scientific and Technical Consulting Services541690
SIC code1 code
  • Services-Computer Programming Services7371
Product category
Medical Device Regulatory & Software Consulting
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1FDA Regulatory Consulting
TypeProfessional Services
Description

Professional consulting services for FDA regulatory strategy, 510(k) submissions, De Novo requests, Breakthrough Device Designation applications, and FDA hold letter responses. Revenue generated through project-based engagements with guaranteed outcomes.

innolitics.com
2Software Development Services
TypeProfessional Services
Description

End-to-end SaMD development including AI/ML algorithm development, software engineering, and FDA documentation. Revenue through fixed-price project engagements with timeline guarantees.

innolitics.com
3FDA Cybersecurity Services
TypeProfessional Services
Description

Cybersecurity documentation and consulting for FDA submissions, including threat modeling, SBOM creation, and response to FDA cybersecurity hold letters.

innolitics.com
4Quality Management System (QMS) Services
TypeProfessional Services
Description

QMS implementation and support services with guaranteed 2-month delivery timeline.

innolitics.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Innolitics is an engineering, regulatory, and management consulting firm that delivers end-to-end services for AI-enabled medical device software (SaMD). Its offerings span full-stack medical device software development, FDA regulatory strategy and submissions (510(k), De Novo, BDD, Q-Sub), FDA cybersecurity documentation and hold-letter response, and quality management system (QMS) implementation. Engagements are delivered with guaranteed timelines and outcomes, consolidating clinical, engineering, and regulatory expertise under one roof.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Typical timeline from 2 years compressed to 6 months for FDA clearance
+5 more records
Product overview1 text field

Innolitics is an engineering, regulatory, and management consulting firm focused exclusively on AI-enabled medical device software. The company provides a portfolio of consulting services and solutions organized around FDA regulatory affairs for medical devices, particularly AI/ML SaMD (Software as a Medical Device). Core services include Software Development (end-to-end SaMD), FDA Regulatory Consulting, and FDA Cybersecurity. Solutions include Guaranteed AI/ML FDA Clearance (9-month timeline), FDA Hold Letter Response, Regulatory Strategy with Q-Sub and BDD in 4 Weeks, Guaranteed Breakthrough Device Designation in 2 Weeks, Guaranteed QMS in 2 Months, and Medical Imaging AI Development. Additionally, Innolitics offers free public tools including the FDA Devices Database (for searching FDA 510(k) clearances) and DICOM Browser (web-based DICOM viewer). The company also maintains an open-source Regulatory Documentation Manager (RDM) for medical device design controls.

Product and service12 records
1Software Development (End-to-End SaMD)
CategorySoftware Development Service
Description

Full-stack medical device software development service for new or existing products, including AI/ML algorithm development, web development, and FDA compliance, for medical device companies building SaMD.

2FDA Regulatory Consulting
CategoryRegulatory Consulting Service
Description

Regulatory strategy and consulting service to determine the best path to US market or address custom regulatory needs for medical device companies.

3FDA Cybersecurity
CategoryCybersecurity Consulting Service
Description

Cybersecurity document preparation service for FDA submissions and response to Hold Letters, covering threat modeling, SBOMs, and vulnerability monitoring for medical device companies.

4Guaranteed AI/ML FDA Clearance
CategoryGuaranteed-Outcomes Solution
Description

Outcome-guaranteed solution for AI/ML SaMD FDA submission and clearance in 9 months, covering 510(k) and De Novo pathways, for medical device companies seeking first-time or repeat AI/ML clearance.

5FDA Hold Letter Response
CategoryGuaranteed-Outcomes Solution
Description

Resolution service for FDA-identified major cybersecurity, software, or AI/ML deficiencies to clear hold letters and achieve FDA clearance, for medical device companies facing submission setbacks.

6Regulatory Strategy, Q-Sub, and BDD in 4 Weeks
CategoryGuaranteed-Outcomes Solution
Description

Guaranteed presubmission (Q-Sub) and Breakthrough Device Designation (BDD) application delivered in 4 weeks, with optional 2-week rush delivery, for AI/ML medical device companies seeking expedited regulatory positioning.

7Guaranteed Breakthrough Device Designation
CategoryGuaranteed-Outcomes Solution
Description

Guaranteed Breakthrough Device Designation (BDD) application in 2 weeks to unlock funding, accelerate FDA review, and signal market leadership, for medical device companies pursuing breakthrough status.

8Guaranteed QMS in 2 Months
CategoryGuaranteed-Outcomes Solution
Description

Quality Management System (QMS) implementation and support service with guaranteed 2-month delivery, for medical device companies needing compliant QMS infrastructure.

9Medical Imaging AI Development
CategoryVertical Solution
Description

Product development partnership for AI-enabled medical imaging applications including CT, MRI, radiology, and pathology imaging, for medical imaging AI companies.

10FDA Devices Database
CategoryPublic Resource / Tool
Description

Publicly accessible database of FDA-cleared medical devices, searchable by 510(k) number and other criteria, provided free to the public.

11DICOM Browser
CategoryPublic Resource / Tool
Description

Web-based DICOM image viewer and browser tool for medical imaging analysis, provided free to the public.

12Regulatory Documentation Manager (RDM)
CategoryOpen-Source Tool
Description

Open-source regulatory documentation manager built by Innolitics for medical device design controls and FDA compliance documentation.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Veeva provides life sciences regulatory, quality, and clinical SaaS solutions across pharma and medical devices, serving as a broader technology incumbent that intersects with Innolitics' regulatory content and QMS adjacencies.

2NAMSA
TypeDirect peer
Description

NAMSA is a medical device-focused CRO offering regulatory strategy, testing, and clinical evaluation services — a long-standing peer for full-cycle medical device regulatory engagements similar to Innolitics' offerings.

3Propel (by Lighthouse)
TypeRegional player
Description

ResMed-owned Propel provides regulatory, quality, and clinical consulting for medical device companies, comparable as a regional-adjacent consulting peer with overlap in FDA submission support.

TypeEmerging player
Description

Pro-ficiency uses simulation-based training and protocol compliance tools for clinical trials, adjacent to Innolitics' compliance and process focus for medical device software development.

TypeBroad incumbent
Description

MasterControl provides enterprise QMS, regulatory, and quality management software across life sciences, serving as a broader incumbent that overlaps with Innolitics' QMS services but across multiple regulated verticals.

TypeEmerging player
Description

Galen Data provides validated cloud-based software and compliance services for medical device SaaS companies, comparable to Innolitics as an emerging player in SaMD regulatory/compliance enablement.

TypeDirect peer
Description

Greenlight Guru offers QMS and design control software purpose-built for medical device companies, directly overlapping with Innolitics' QMS implementation and documentation services.

TypeDirect peer
Description

CompliancePath provides regulatory and quality consulting for medical device companies including 510(k) submissions, QMS, and remediation work, competing directly with Innolitics for AI/SaMD regulatory clients.

TypeDirect peer
Description

RQM+ is a medical device regulatory and quality consulting firm providing 510(k), CE marking, QMS, and clinical strategy services — the closest direct competitor to Innolitics' end-to-end SaMD regulatory practice.

TypeEmerging player
Description

RegDesk is a regulatory intelligence and compliance platform for medical device and IVD companies, an emerging technology peer to Innolitics' content-driven regulatory tools.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Innolitics

Medical Device Regulatory & Software Consultinginnolitics.com

Innolitics is an Austin-based engineering and regulatory consulting firm that helps AI/ML medical device startups and enterprises achieve FDA clearance for SaMD products. Founded in 2012, the firm offers guaranteed-outcome services spanning software development, regulatory strategy, and cybersecurity compliance.

What Innolitics does

Innolitics is an Austin, Texas-based engineering, regulatory, and management consulting firm founded in 2012 that focuses exclusively on AI-enabled medical device software (Software as a Medical Device). The firm helps medical device CEOs and founders convert clinical AI concepts into FDA-cleared, market-ready products by offering a vertically integrated delivery model that combines software engineering, FDA regulatory strategy, and cybersecurity compliance under a single engagement. Headquartered at 1101 West 34th St. #550, Innolitics operates as Innolitics LLC with no disclosed external institutional or venture funding and a headcount of 11–50 employees.

The service portfolio is organized around four core capabilities: end-to-end SaMD software development, FDA regulatory consulting (including 510(k), De Novo, Q-Sub, and Breakthrough Device Designation pathways), FDA cybersecurity documentation and hold-letter response, and Quality Management System implementation. Building on these services, Innolitics has productized a 'solutions' tier with fixed-scope, guaranteed-outcome offerings — 9-month AI/ML FDA clearance, 2-week BDD application, 4-week presub plus BDD, 2-month QMS delivery, and 3-month FDA hold-letter resolution. The firm also operates free public tools (an FDA Devices Database at fda.innolitics.com and a web-based DICOM Browser) and maintains an open-source Regulatory Documentation Manager (RDM) on GitHub, all of which function as lead-generation channels into the core services business.

Innolitics generates revenue through fixed-price or milestone-based professional services engagements; no public pricing is disclosed. Its customer base spans AI/ML medical imaging startups (Rology, Envisionit Deep AI, SimBioSys, Body Check, RadUnity, SmileDx/Cube Click, Neosoma, Prognosia Breast), enterprises (Varian Medical Systems, NVIDIA, Butterfly Network, Prenuvo, Indica Labs, Magnetic Insight, Transonic, AI Metrics, OXOS, Echo IQ, Enlitic, PhotoniCare), and academic institutions (Washington University School of Medicine, University of Alabama, Mary Bird Perkins Cancer Center), with reported cumulative outcomes of 60+ FDA-cleared products and 80+ devices shipped. The go-to-market motion is sales-led and relationship-based, targeting founders and regulatory teams at medical device companies through content marketing, a newsletter, and direct outreach.

Innolitics firmographics

Firmographics
Name
Innolitics
Legal name
Innolitics LLC
Website
https://innolitics.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
11–50 employees
Short description
Innolitics is an Austin-based engineering and regulatory consulting firm that helps AI/ML medical device startups and enterprises achieve FDA clearance for SaMD products. Founded in 2012, the firm offers guaranteed-outcome services spanning software development, regulatory strategy, and cybersecurity compliance.
Ownership category
akta.pro rank

Innolitics industry classification

Industry
Product category
Medical Device Regulatory & Software Consulting
NAICS
Computer Systems Design and Related Services (54151), Other Scientific and Technical Consulting Services (541690)
SIC
Services-Computer Programming Services (7371)
akta.pro industry
PRIMARYHLACANAN
DTx/SaMD Regulatory, Quality & Compliance Software (QMS/ISO/FDA)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAD
Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • FDA regulatory consulting
  • Medical device software
  • AI/ML SaMD development
  • FDA 510(k) clearance
  • Medical device cybersecurity

Where Innolitics is headquartered

Location

Headquarters

HQ city
Austin
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Innolitics business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. FDA Regulatory Consulting: Professional consulting services for FDA regulatory strategy, 510(k) submissions, De Novo requests, Breakthrough Device Designation applications, and FDA hold letter responses. Revenue generated through project-based engagements with guaranteed outcomes.
  2. Software Development Services: End-to-end SaMD development including AI/ML algorithm development, software engineering, and FDA documentation. Revenue through fixed-price project engagements with timeline guarantees.
  3. FDA Cybersecurity Services: Cybersecurity documentation and consulting for FDA submissions, including threat modeling, SBOM creation, and response to FDA cybersecurity hold letters.
  4. Quality Management System (QMS) Services: QMS implementation and support services with guaranteed 2-month delivery timeline.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Innolitics product offering

Product offering

Core offering

Innolitics is an engineering, regulatory, and management consulting firm that delivers end-to-end services for AI-enabled medical device software (SaMD). Its offerings span full-stack medical device software development, FDA regulatory strategy and submissions (510(k), De Novo, BDD, Q-Sub), FDA cybersecurity documentation and hold-letter response, and quality management system (QMS) implementation. Engagements are delivered with guaranteed timelines and outcomes, consolidating clinical, engineering, and regulatory expertise under one roof.

Product overview

Innolitics is an engineering, regulatory, and management consulting firm focused exclusively on AI-enabled medical device software. The company provides a portfolio of consulting services and solutions organized around FDA regulatory affairs for medical devices, particularly AI/ML SaMD (Software as a Medical Device). Core services include Software Development (end-to-end SaMD), FDA Regulatory Consulting, and FDA Cybersecurity. Solutions include Guaranteed AI/ML FDA Clearance (9-month timeline), FDA Hold Letter Response, Regulatory Strategy with Q-Sub and BDD in 4 Weeks, Guaranteed Breakthrough Device Designation in 2 Weeks, Guaranteed QMS in 2 Months, and Medical Imaging AI Development. Additionally, Innolitics offers free public tools including the FDA Devices Database (for searching FDA 510(k) clearances) and DICOM Browser (web-based DICOM viewer). The company also maintains an open-source Regulatory Documentation Manager (RDM) for medical device design controls.

Differentiator

Problem solved

Functional benefit

Products and services

  • Software Development (End-to-End SaMD) Full-stack medical device software development service for new or existing products, including AI/ML algorithm development, web development, and FDA compliance, for medical device companies building SaMD.
  • FDA Regulatory Consulting Regulatory strategy and consulting service to determine the best path to US market or address custom regulatory needs for medical device companies.
  • FDA Cybersecurity Cybersecurity document preparation service for FDA submissions and response to Hold Letters, covering threat modeling, SBOMs, and vulnerability monitoring for medical device companies.
  • Guaranteed AI/ML FDA Clearance Outcome-guaranteed solution for AI/ML SaMD FDA submission and clearance in 9 months, covering 510(k) and De Novo pathways, for medical device companies seeking first-time or repeat AI/ML clearance.
  • FDA Hold Letter Response Resolution service for FDA-identified major cybersecurity, software, or AI/ML deficiencies to clear hold letters and achieve FDA clearance, for medical device companies facing submission setbacks.
  • Regulatory Strategy, Q-Sub, and BDD in 4 Weeks Guaranteed presubmission (Q-Sub) and Breakthrough Device Designation (BDD) application delivered in 4 weeks, with optional 2-week rush delivery, for AI/ML medical device companies seeking expedited regulatory positioning.
  • Guaranteed Breakthrough Device Designation Guaranteed Breakthrough Device Designation (BDD) application in 2 weeks to unlock funding, accelerate FDA review, and signal market leadership, for medical device companies pursuing breakthrough status.
  • Guaranteed QMS in 2 Months Quality Management System (QMS) implementation and support service with guaranteed 2-month delivery, for medical device companies needing compliant QMS infrastructure.
  • Medical Imaging AI Development Product development partnership for AI-enabled medical imaging applications including CT, MRI, radiology, and pathology imaging, for medical imaging AI companies.
  • FDA Devices Database Publicly accessible database of FDA-cleared medical devices, searchable by 510(k) number and other criteria, provided free to the public.
  • DICOM Browser Web-based DICOM image viewer and browser tool for medical imaging analysis, provided free to the public.
  • Regulatory Documentation Manager (RDM) Open-source regulatory documentation manager built by Innolitics for medical device design controls and FDA compliance documentation.

Quantifiable outcome

  • Typical timeline from 2 years compressed to 6 months for FDA clearance
  • +5 more outcomes

Companies that use Innolitics

Customer profile

Named customers12 records

Segments4 records

Ideal customer profiles4 records

Innolitics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

Innolitics partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Innolitics competitors and assessment

Company assessment

Broad incumbents

  • Veeva Systems: Veeva provides life sciences regulatory, quality, and clinical SaaS solutions across pharma and medical devices, serving as a broader technology incumbent that intersects with Innolitics' regulatory content and QMS adjacencies.
  • MasterControl: MasterControl provides enterprise QMS, regulatory, and quality management software across life sciences, serving as a broader incumbent that overlaps with Innolitics' QMS services but across multiple regulated verticals.

Direct peers

  • NAMSA: NAMSA is a medical device-focused CRO offering regulatory strategy, testing, and clinical evaluation services — a long-standing peer for full-cycle medical device regulatory engagements similar to Innolitics' offerings.
  • Greenlight Guru (by MasterControl): Greenlight Guru offers QMS and design control software purpose-built for medical device companies, directly overlapping with Innolitics' QMS implementation and documentation services.
  • CompliancePath: CompliancePath provides regulatory and quality consulting for medical device companies including 510(k) submissions, QMS, and remediation work, competing directly with Innolitics for AI/SaMD regulatory clients.
  • RQM+: RQM+ is a medical device regulatory and quality consulting firm providing 510(k), CE marking, QMS, and clinical strategy services — the closest direct competitor to Innolitics' end-to-end SaMD regulatory practice.

Regional players

  • Propel (by Lighthouse): ResMed-owned Propel provides regulatory, quality, and clinical consulting for medical device companies, comparable as a regional-adjacent consulting peer with overlap in FDA submission support.

Emerging players

  • Pro-ficiency: Pro-ficiency uses simulation-based training and protocol compliance tools for clinical trials, adjacent to Innolitics' compliance and process focus for medical device software development.
  • Galen Data: Galen Data provides validated cloud-based software and compliance services for medical device SaaS companies, comparable to Innolitics as an emerging player in SaMD regulatory/compliance enablement.
  • RegDesk (by Ardent>): RegDesk is a regulatory intelligence and compliance platform for medical device and IVD companies, an emerging technology peer to Innolitics' content-driven regulatory tools.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Innolitics social profiles

Digital presence

Innolitics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Innolitics leadership team

Management profile

Number of profiles

Innolitics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Innolitics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innolitics

What does Innolitics do?

Innolitics is an engineering, regulatory, and management consulting firm that delivers end-to-end services for AI-enabled medical device software (SaMD). Its offerings span full-stack medical device software development, FDA regulatory strategy and submissions (510(k), De Novo, BDD, Q-Sub), FDA cybersecurity documentation and hold-letter response, and quality management system (QMS) implementation. Engagements are delivered with guaranteed timelines and outcomes, consolidating clinical, engineering, and regulatory expertise under one roof.

Is Innolitics a public or private company?

Innolitics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Innolitics founded?

Innolitics was founded in 2012. It employs 11 to 50 people.

Where is Innolitics based?

Innolitics is headquartered in Austin, United States, in the North America region.

How does Innolitics make money?

Four revenue lines are on record. FDA Regulatory Consulting is the primary driver. The others are software Development Services, FDA Cybersecurity Services and quality Management System (QMS) Services.

Who are Innolitics's main competitors?

Broad incumbents on record are Veeva Systems and MasterControl. Direct peers are NAMSA, Greenlight Guru (by MasterControl), CompliancePath and RQM+. Propel (by Lighthouse) is listed as a regional player. Emerging players are Pro-ficiency, Galen Data and RegDesk (by Ardent>).

Does Innolitics have an API?

No public API is recorded for Innolitics.

What industry is Innolitics in?

Innolitics's product category is Medical Device Regulatory & Software Consulting. Its primary akta.pro industry code is HLACANAN, DTx/SaMD Regulatory, Quality & Compliance Software (QMS/ISO/FDA), with a secondary code of HLACANAD, Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software. Its NAICS code is 54151 and its SIC code is 7371.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinancialContent Business PageDeep Reasoning AI and Innolitics Achieve FDA 510(k) Clearance for NeuroDR, AI Software for Neurovascular CT AngiographyDeep Reasoning AI and Innolitics received FDA 510(k) clearance for NeuroDR, AI software that automates visualization of head and neck arteries from CT angiography scans. The clearance was granted 105 days after submission, and the company plans to bring the product to U.S. hospitals and imaging centers.FinancialContent Business PageMonebo and Innolitics Secure FDA 510(k) Clearance for a Cross-Platform ECG Arrhythmia Analysis LibraryMonebo Technologies and Innolitics announced FDA 510(k) clearance for the Kinetic Software Library, an ECG analysis library for medical device manufacturers. The library provides beat detection, heart rate, and rhythm analysis, and Monebo has 51 prior clearances tracing back to its 2002 library.AijournHeartvue.ai and Innolitics Achieve FDA 510(k) Clearance for Heartvue.Proton, an AI-Powered Cardiac MRI Analysis PlatformHeartvue.ai and Innolitics received FDA 510(k) clearance for Heartvue.Proton, an AI-powered cardiac MRI analysis platform, on their first submission. The clearance includes a Predetermined Change Control Plan, allowing pre-approved model updates without new submissions. Heartvue.ai will begin commercial rollout to U.S. hospitals and imaging centers.Business Wire BlogHeartvue.ai and Innolitics Achieve FDA 510(k) Clearance for Heartvue.Proton, an AI-Powered Cardiac MRI Analysis PlatformHeartvue.ai and Innolitics announced FDA 510(k) clearance for Heartvue.Proton, an AI platform for cardiac MRI analysis. The clearance includes a Predetermined Change Control Plan, allowing pre-approved model updates. Heartvue will begin commercial rollout to U.S. hospitals.FinancialContent Business PageHeartvue.ai and Innolitics Achieve FDA 510(k) Clearance for Heartvue.Proton, an AI-Powered Cardiac MRI Analysis PlatformHeartvue.ai and Innolitics received FDA 510(k) clearance for Heartvue.Proton, an AI-powered cardiac MRI analysis platform, on its first submission. The clearance includes a Predetermined Change Control Plan, allowing pre-approved model updates. Heartvue.ai will begin commercial rollout to U.S. hospitals and imaging centers.Business Wire BlogInnolitics and BEACON-Neuro.AI Partner to Bring FDA Breakthrough Device BEACONPredict to MarketInnolitics and BEACON-Neuro.AI announced a partnership to commercialize BEACONPredict, AI software that predicts malignant cerebral edema risk after acute ischemic stroke. The tool received FDA Breakthrough Device Designation on its first review cycle and entered the FDA's TAP pilot, with a De Novo pathway underway. BEACON-Neuro.AI is raising a $0.5M pre-seed and $2.7M seed round.FinancialContent Business PageInnolitics and BEACON-Neuro.AI Partner to Bring FDA Breakthrough Device BEACONPredict to MarketInnolitics and BEACON-Neuro.AI, a Washington University in St. Louis startup, announced a partnership to commercialize BEACONPredict, AI software that predicts malignant cerebral edema risk after acute ischemic stroke. The tool received FDA Breakthrough Device Designation on its first review cycle and entered the FDA's TAP pilot, with a De Novo pathway underway. BEACON-Neuro.AI is raising a $0.5M pre-seed round followed by a $2.7M seed round.Stock TitanPetros Pharma Secures $10M for First FDA-Compliant OTC Drug PlatformPetros Pharmaceuticals announced a partnership with Innolitics to integrate software for its FDA-compliant OTC drug platform. The company has over $10M in cash and a reduced burn rate, positioning it to fund development. The platform targets the $38B self-care market and supports Rx-to-OTC switches.FinancialContent Business PagePetros Pharmaceuticals Partners with Innolitics, a Leading Software-as-a-Medical-Device DeveloperPetros Pharmaceuticals announced a partnership with Innolitics to integrate software for its SaaS platform, aiming to support Rx-to-OTC switches. The company holds over $10 million in cash and a reduced burn rate, positioning it to fund development. The platform targets the $38 billion self-care market under FDA ACNU guidelines.Investing.comPetros Pharmaceuticals partners with Innolitics for SaaS platform By Investing.comPetros Pharmaceuticals announced a partnership with Innolitics to enhance its SaaS platform for Rx-to-OTC drug transitions. The company reported $5.1 million revenue and a 76% gross profit margin, but faces cash-burn concerns. The platform aims to support FDA ACNU guidelines and the $38 billion self-care market.